Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin

Prevalence of diabetes mellitus is inc6reasing, with a burden of 382 million patients worldwide at present (more than the entire US population). The International Diabetes Federation anticipates an increase up to 592 million patients by 2035. Another major problem arises from the fact that just 50%...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, B, Eckstein, N, Pfeifer, V, Mayer, P, Hass, M D S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259905/
https://www.ncbi.nlm.nih.gov/pubmed/25365416
http://dx.doi.org/10.1038/nutd.2014.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259905/
https://www.ncbi.nlm.nih.gov/pubmed/25365416
http://dx.doi.org/10.1038/nutd.2014.40

Ejemplares similares